|
|
Volumn 41, Issue 4, 2001, Pages 455-458
|
|
Effect of alosetron on the pharmacokinetics of fluoxetine
a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALOSETRON;
ANTIDEPRESSANT AGENT;
FLUOXETINE;
NORFLUOXETINE;
SEROTONIN 3 ANTAGONIST;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONCENTRATION RESPONSE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DEPRESSION;
DRUG CROSS REACTIVITY;
DRUG METABOLISM;
DRUG RECEPTOR BINDING;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
HUMAN CELL;
HUMAN EXPERIMENT;
HUMAN TISSUE;
IRRITABLE COLON;
MALE;
NORMAL HUMAN;
ADMINISTRATION, ORAL;
ADULT;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
BIOLOGICAL AVAILABILITY;
CARBOLINES;
COLON;
COLONIC DISEASES, FUNCTIONAL;
CROSS-OVER STUDIES;
CYTOCHROME P-450 ENZYME SYSTEM;
DRUG INTERACTIONS;
FEMALE;
FLUOXETINE;
GENOTYPE;
HALF-LIFE;
HUMANS;
ISOENZYMES;
MALE;
METABOLIC CLEARANCE RATE;
MIDDLE AGED;
SEROTONIN ANTAGONISTS;
TIME FACTORS;
|
|
EID: 0035066728
PISSN: 00912700
EISSN: None
Source Type: Journal
DOI: 10.1177/00912700122010177 Document Type: Article |
|
Times cited : (14)
|
|
References (11)
|
